Sarcomatous transformation of an IDH-mutant oligodendroglioma matching to methylation class oligosarcoma despite vorasidenib use, a case report

Clicks: 8
ID: 333677
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #142 of 144 articles by views in Neuro-Oncology Advances

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 144 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Lay Summary Oligodendroglioma is a brain tumor that usually grows relatively slowly but can become more aggressive over time. We describe a rare case in which an oligodendroglioma progressed and transformed into oligosarcoma, a recently recognized aggressive tumor type, despite treatment with vorasidenib, a drug targeting the IDH mutation that drives these tumors. Genetic testing confirmed that the transformed tumor remained related to the original cancer while acquiring additional important molecular changes. This case demonstrates that tumor evolution may continue despite targeted IDH therapy and highlights the importance of repeat biopsies and molecular testing when tumors progress or behave in unexpected ways.
Reference Key
openalex_W7223339727 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal Neuro-Oncology Advances
Year 2026
DOI
10.1093/noajnl/vdag263
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.